Alpe d'HuZes cancer rehabilitation (A-CaRe) research: four randomized controlled exercise trials and economic evaluations in cancer patients and survivors.

Introduction

Recent advances in diagnosis and treatment of cancer patients have led to improved survival rates, both for children and adults. In The Netherlands, the current 5-year survival rate across all cancers is approximately 62% for female and 56% for male patients [ 1 ]. The survival rates of childhood cancer have improved up to 75% [ 2 , 3 ]. However, cancer treatment and survival are often associated with prolonged psychosocial and physical complaints [ 4 , 5 ], including decreased muscle strength, reduced lean body mass, reduced cardiorespiratory fitness, bone loss and fatigue [ 6 ]. For example, approximately 70% of cancer patients report fatigue complaints during chemotherapy and/or radiotherapy [ 7 – 9 ], and even years after the end of therapy, fatigue is still a major problem for at least 30% of cancer survivors [ 9 ]. Feelings of fatigue may result in the avoidance of activities to reduce the discomfort. However, this may result in a self-perpetuating condition of diminished activity leading to reduced physical fitness, increased muscle wasting and consequently to easy fatigue and further physical inactivity [ 6 , 9 ]. This has great impact on the patient’s quality of life [ 7 , 9 ]. This is also true for survivors of childhood cancer [ 10 ]. Geenen et al. reported that 75% of childhood cancer survivors had at least one adverse health effect after a median follow-up of 17 years [ 11 ]. Late health effects include adverse general and mental health, activity limitations, functional impairments [ 2 ], reduced physical fitness, increased fatigue and reduced health-related quality of life (HRQoL) [ 12 ].

Several literature reviews summarized the available scientific literature on the effects of exercise interventions in adult cancer patients and survivors [ 4 , 13 – 18 ]. These studies suggest that cancer patients may benefit from physical exercise both during and after treatment. The suggested beneficial effects include improved physical performance, self-reported functioning and psychological and social well-being, as well as reduced fatigue and increased quality of life [ 4 , 13 , 14 , 16 – 18 ]. The majority of the studies focused on patients with breast cancer, and fewer studied colorectal, lung and prostate cancers [ 13 , 15 , 16 ]. A recent literature review of Liu et al. [ 15 ] reported that physical exercise interventions were also feasible to conduct in haematological cancer patients and that results on physical fitness, HRQoL and psychological well-being were encouraging [ 15 ].

However, evidence of the beneficial effects of exercise in cancer patients and survivors appeared to be limited due to poor to moderate methodological quality of the studies. Most studies were not randomized controlled trials (RCTs), did not include appropriate control groups and/or were based on small sample sizes. Furthermore, most exercise interventions were sub-optimal regarding exercise physiological aspects: Exercise programmes were relatively short in duration (less than 12 weeks) and did not systematically promote maintenance of physical activity among the patients after the programme, and most studies included only low-intensity aerobic exercise, such as walking or cycling, rather than resistance exercise and high-intensity exercise [ 13 , 16 , 19 ]. Since muscle atrophy is a common problem in cancer patients [ 20 ], it seems advisable to include resistance exercises as well. With appropriate training stimuli, skeletal muscles can show great adaptability even in case of severe muscle atrophy and fatigue [ 6 ].

In The Netherlands, a cancer rehabilitation programme ‘Recovery & Stability’ [ 21 , 22 ] exists. This is a 12-week supervised self-management exercise programme of low-to-moderate intensity that combines endurance and resistance exercises with group sports activities. The Recovery & Stability programme showed improvements in physical fitness [ 21 ] and quality of life [ 23 ], which sustained 9 months post-intervention [ 23 ], but the study did not include a no-exercise control group. Another cancer rehabilitation programme in The Netherlands included high-intensity resistance and endurance training after chemotherapy treatment and showed improved physical performance and quality of life in cancer patients compared with a historical control group [ 19 ]. These effects persisted at 1 year follow-up [ 24 ].

In summary, previous studies showed that exercise-based rehabilitation programmes of moderate or high intensity are feasible and well tolerated by adult cancer patients and survivors. However, RCTs including adequate sample sizes, an appropriate control group and valid and reliable outcome measures are limited. Furthermore, no studies have examined the cost-effectiveness of any type of exercise programme in cancer patients. Therefore, a cancer rehabilitation research programme was proposed to and approved by the Dutch Cancer Society, financed through this society by the so-called Alpe d’HuZes foundation ( www.opgevenisgeenoptie.nl ), a cancer research fund. This Alpe d’HuZes Cancer Rehabilitation (A-CaRe) programme includes a clinical research subprogramme (A-CaRe Clinical Research) in addition to subprogrammes aiming at patient empowerment and public relations. The primary objectives of A-CaRe Clinical Research are to evaluate the effectiveness of state-of-the-art exercise interventions with respect to physical fitness and fatigue and secondarily HRQoL in specific cancer patient and survivor groups and to evaluate the cost-effectiveness of these interventions. The present paper describes the design of the A-CaRe Clinical Research programme.

Methods

A-CaRe Clinical Research includes four RCTs with follow-up periods up to 1 year focusing on different subgroups: (a) exercise after chemotherapy [ 25 ], (b) exercise during chemotherapy [ 26 ], (c) exercise after stem cell transplantation [ 27 ] and (d) exercise during childhood cancer [ 28 ] (Table 1 ). Table 1 Intervention and control arms of the A-CaRe trials 1. Exercise after chemotherapy 2. Exercise during chemotherapy 3. Exercise after SCT 4. Exercise during childhood cancer Intervention duration 12 weeks Depending on duration of chemotherapy 18 weeks 12 weeks Intervention arm 1 High-intensity resistance and endurance exercise High-intensity resistance and endurance exercise High-intensity resistance and endurance exercise High-intensity resistance and endurance exercise Intervention arm 2 Low-to-moderate intensity resistance and endurance exercise Low-to-moderate intensity physical activity programme – – Control arm Waiting list a Usual care Usual care b Usual care SCT stem cell transplantation a After 12 weeks, patients will start with the high-intensity resistance and endurance programme or the light-to-moderate intensity exercise programme, depending on which programme they have been allocated to b Currently, 10–20% of patients after SCT participate in the Recovery & Stability programme, in most cases starting 6 months or longer after transplantation

The design of the A-CaRe trials is based on a conceptual model, presented in Fig. 1 . According to this model, exercise improves physical fitness (cardiorespiratory fitness and muscle strength), which improves fatigue and subsequently also physical function and HRQoL. Physical fitness may also directly influence physical function and HRQoL. Fig. 1 Conceptual model of the A-CaRe trials

In the A-CaRe trials, exercise interventions will be compared with either a waiting list control group or usual care. All four A-CaRe trials will use similar methods.

Study Population

Potentially eligible patients will be screened by the treating physician for the presence of comorbid conditions that would contraindicate participation in a physical exercise programme. This includes patients who are wheelchair dependent or not able to perform basic physical activities like walking or cycling, patients with contraindications for physical activity or exercise (i.e. serious orthopaedic conditions that would hamper functional recovery, serious cardiovascular or cardiopulmonary risks), patients with serious psychiatric or cognitive problems or severe emotional instability, patients suffering from malnutrition (evidenced by an unintended weight loss of more than 5% per month or more than 10% unintended weight loss during the previous 6 months), patients not being familiar with the Dutch language, patients who are unable to follow exercise instructions and patients participating in concurrent studies or rehabilitation programmes containing physical activity or exercise. Due to the focus on different patient populations, each A-CaRe study has its own inclusion criteria. Table 2 presents the inclusion criteria for each RCT, as well as additional trial-specific exclusion criteria. Table 2 Number of patients, participating hospitals and in- and exclusion criteria of the A-CaRe trials Project # of patients Inclusion criteria Specific exclusion criteria a Participating hospitals 1. Exercise after chemotherapy 400 Histological confirmed breast, colon, ovarian cancer or lymphomas with no indication of recurrent or progressive disease Maxima Medical Center Veldhoven/Eindhoven, Catharina Hospital Eindhoven, Elckerlieck Hospital Helmond, Sint Anna Hospital, Geldrop, VU University Medical Center Amsterdam Aged between 18 and 70 years Completion of (adjuvant) chemotherapy with curative intention and completion of surgical treatment or radiotherapy 2. Exercise during chemotherapy 360 Histological confirmed primary breast of primary colon cancer who are scheduled to undergo adjuvant chemotherapy Amstelland Hospital, Antoni van Leeuwenhoek Hospital, Bovenij Hospital, Flevohospital, Medical Center Alkmaar, Onze Lieve Vrouwe Gasthuis, Rode Kruis Hospital Beverwijk, Sint Lucas Andreas Hospital, Spaarne Hospital Hoofddorp, VU University Medical Center Amsterdam, Waterland Hospital, Zaans Medical Center 3. Exercise after SCT 120 Haematological malignancies undergoing high dose chemotherapy and autologous SCT Multiple myeloma undergoing a tandem autologous–allogeneic SCT Academic Medical Centre Amsterdam, Antoni van Leeuwenhoek Hospital Amsterdam, University Medical Center Utrecht, Antonius Hospital Nieuwegein, Haga Hospital The Hague Multiple myeloma in first line; Hodgkin’s lymphoma or non-Hodgkin’s lymphoma in first relapse Extensive osteolytic lesions with risk of fracture Aged between 18 and 65 years Severe infections Sufficiently recovered from the SCT and having peripheral blood recovery 4. Exercise during childhood cancer 100 Aged 8–18 years at the time of intervention Bone marrow transplantation Centre for Paediatric Oncology and Haematology of VU University Medical Center, Wilhelmina Children’s Hospital University Medical Centre Utrecht, Emma Children’s Hospital Academic Medical Center Amsterdam Diagnosed with any type of childhood malignancy Growth hormone treatment Treated with chemo- and or radiotherapy No longer than 12 months off treatment SCT Stem cell transplantation a All four studies exclude patients who are wheelchair dependent or not able to perform basic activities like walking or cycling, patients with contraindications for physical activity or exercise (i.e. serious orthopaedic conditions that would hamper functional recovery, serious cardiovascular or cardiopulmonary risks), patients with serious psychiatric or cognitive problems or severe emotional instability, patients suffering from malnutrition (evidenced by an unintended weight loss of more than 5% per month or more than 10% unintended weight loss during the previous 6 months), patients not being familiar with the Dutch language, patients who are unable to follow exercise instructions and patients participating in concurrent studies or rehabilitation programmes containing physical activity or exercise

Exercise Interventions

Table 1 presents the intervention and control arms of all four A-CaRe trials. In general, the exercise interventions consist of high-intensity resistance and endurance exercises under supervision of a physical therapist twice a week, with a duration of 60 min. Furthermore, all interventions include a behavioural motivation component aimed at increasing motivation and compliance to physical exercise. Patients who completed treatment trained for 12 weeks. The Recovery & Stability programme showed that an intervention duration of 12 weeks was sufficient to achieve beneficial effects on physical fitness and HRQoL [ 21 ]. Also De Backer et al. [ 19 ] showed the largest improvements in physical fitness to occur in the first 12 weeks training. However, patients after stem cell transplantation who are treated more aggressively are at increased risk for persistent complaints [ 29 ]; they are more likely to have lower levels of physical fitness and higher levels of fatigue and consequently may need more time to recover. Therefore, for these patients, the intervention duration was extended to 18 weeks.

In general, the high-intensity resistance programme will consist of exercises targeting the large muscle groups of the upper and lower extremities. Resistance exercises are performed at 65% to 80% of the one repetition maximum (1-RM), consisting of two sets of 10–15 repetitions. Every 4 weeks, the training progress is evaluated by means of an indirect 1-RM test, and the training intensity is adjusted accordingly.

The high-intensity endurance exercises are performed at an intensity of 65% of the maximal workload of the steep ramp test [ 30 ]. This corresponds to a score of 15 on the Borg scale for ratings of perceived exertion [ 31 ]. Endurance exercises are mainly performed on a cycle ergometer. Additionally, other modes of endurance, such as rowing, will be used depending on the patients’ preferences.

A behavioural motivation component is included to improve compliance and stimulate physical activity outside the exercise programme. Patients are encouraged to be moderately physically active for at least 30 min, three times per week in addition to the supervised programme. After completion of the exercise intervention, patients are encouraged to be moderately physically active for at least 30 min five times per week. Specific programme elements include the provision of general and motivational information, both verbally and via folders, about physical activity and provision of specific advice about the desired intensity of activity based on the Borg scale of rating perceived exertion.

In the studies evaluating the effectiveness of exercise interventions after and during chemotherapy, a second intervention arm is included consisting of low-to-moderate intensity exercise. Detailed descriptions of the interventions are presented elsewhere [ 25 – 28 ].

Assessments and Outcome Measures

All four A-CaRe trials use similar outcome measures, which are carefully chosen based on the International Classification of Functioning, Disability and Health (ICF) of the World Health Organization [ 32 ]. The ICF provides a useful framework for classifying the components of health and consequences of a disease. According to the ICF, the consequences of a disease, in this case cancer (i.e. the type of cancer and its treatment), may concern body functions and structures, as well as the performance of activities and participation in life situations. Health states and the development of disability are modified by contextual factors including personal factors, such as sociodemographic data, and environmental factors, such as societal attitudes and social support [ 32 ]. Furthermore, cancer and its associated impairments, activity limitations and participation restrictions may have consequences for HRQoL (Fig. 2 ). In the ICF classification, the letters b, s, d and e refer to the following components of the classification: body functions, body structures, activities and participation and environmental factors. The hierarchical code system of the ICF consists of the abbreviation of the component and the chapter number (e.g. b4 Functions of the cardiovascular , haematological , immunological and respiratory systems ), followed by the second level (e.g. b455 Exercise tolerance functions ), the third level (e.g. b4551 Aerobic capacity ) and possibly a fourth level. The use of a lower-level (more detailed level) category automatically implies that the higher-level category is also applicable. Fig. 2 The International Classification of Functioning, Disability and Health (ICF) model

In oncology rehabilitation, the ICF framework is suggested to be useful for selection of outcome measures [ 33 ]. In A-CaRe Clinical Research, the outcome measures are carefully selected to assess body functions as well as activities and participation. Table 3 presents an overview of the outcome measures and instrumentation that will be used in A-CaRe Clinical Research, classified according to the ICF. Primary outcome measures are cardiorespiratory fitness, muscle strength and fatigue. Secondary outcome measures include body composition, health-related quality of life, physical activity, mood and sleep disturbances, participation and autonomy, return to work and adverse events. Table 3 The outcome measures and instruments used in the A-CaRe trials, classified according to the ICF International Classification of Functioning, Disability and Health Second level Third level Adults Children Body functions Chapter 1 Mental functions b122 Global psychosocial functions CBCL, YRS b126 Temperament and personality functions CBCL, YRS, CBSA/CBSK (behavioural conduct) b130 Energy drive and functions MFI, FQL PedsQL Multidimensional Fatigue Scale Acute version b134 Sleep functions PSQI b152 Emotional functions HADS CDI b280 Sensations of pain EORTC QLQ-C30 symptom scale Chapter 4 Functions of the cardiovascular, haematological, immunological and respiratory systems b410–b429 Cardiovascular system functions Heart rate Heart rate b440–b449 Respiratory system functions Respiratory rate Respiratory rate b455 Exercise tolerance functions b4551 Aerobic capacity PeakVO 2 PeakVO 2 b4552 Fatigability MFI Chapter 5 Functions related to the digestive, metabolic and respiratory systems b530 Weight maintenance BMI, skinfolds, hip and waist circumference, DEXA scan BMI, DEXA scan Chapter 7 Neuromusculoskeletal and movement-related functions b730 Muscle power function b7304 Power of muscles of all limbs Upper extremity: handgrip strength Handheld dynamometer for upper and lower extremity Lower extremity: 30 s chair stand test Activities and participation Chapter 4 Mobility d410 Changing basic body position d4103 Sitting 30-s chair stand test d4104 Standing 30-s chair stand test d450 Walking PASE and accelerometer Accelerometer d460 Moving around in different locations IPA (mobility and leisure) d4600 Moving around within the home IPA (mobility and leisure) d4601 Moving around within buildings other than home IPA (mobility and leisure) d4602 Moving around outside the home and other buildings IPA (mobility and leisure) d470 Using transportation d4700 Using human-powered vehicles PASE Chapter 5 Self-care d510 Washing oneself IPA (autonomy in self-care) d530 Toileting IPA (autonomy in self-care) d540 Dressing IPA (autonomy in self-care) d550 Eating IPA (autonomy in self-care) d560 Drinking IPA (autonomy in self-care) d570 Looking after one’s health IPA (autonomy in self-care) Chapter 6 Domestic life d620 Acquisition of goods and services d6200 Shopping IPA (family role) d640 Doing housework PASE, IPA (family role) d6402 Cleaning living area IPA (family role) d650 Caring for household objects IPA (family role) Chapter 7 Interpersonal interactions and relationships d750 Informal social relationships IPA (social relations) CBSA/CBSK (close friendships) d7502 Informal relationships with co-inhabitants IPA (social relations) d760 Family relationships IPA (social relations) d770 d7702 Sexual relationships IPA (social relations) Chapter 8 Major life areas d810–d839 Education Level of education Level of education, return to school CBSA/CBSK (scholastic competence) d815 Preschool education Level of education Level of education, return to school d820 School education Level of education Level of education, return to school d825 Vocational training Level of education Level of education, return to school d830 Higher education Level of education Level of education, return to school d840–d959 Work and Employment Type of employment, return to work d850 Remunerative employment Type of employment, return to work d850 Self-employment Type of employment, return to work d8501 Part-time employment d8502 Full-time employment Type of employment, return to work d855 Non-remunerative employment Type of employment, return to work d870 Economic self-sufficiency IPA (family role) IPA (family role) d880 Engagement in play Accelerometer Chapter 9 Community, social and civic life d920 Recreation and leisure IPA (mobility and leisure) IPA (mobility and leisure) d9200 Play Accelerometer d9201 Sports PASE and accelerometer Accelerometer BMI body mass index, CBCL Child Behaviour Checklist, CBSA self-perception profile for adolescents, CBSK self-perception profile for children, CDI Child’s Depression Inventory, DEXA dual energy X-ray, EORTC QLQ-C30 European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire C30, FQL Fatigue Quality list, HADS Hospital Anxiety and Depression Scale, IPA Impact on Participation and Autonomy, MFI Multidimensional Fatigue Inventory, PSQI Pittsburgh Sleep Quality Index, VO 2 oxygen uptake

All outcome measures are assessed at baseline, prior to randomization (T0), at completion of the intervention (T1) and at follow-up (T2). Follow-up measurements will be performed 12 months after completion of the intervention. In the RCT evaluating exercise during chemotherapy, T2 measurements take place 6 months after completion of the intervention.

Primary Outcome Measures

Cardiorespiratory Fitness

Cardiorespiratory fitness is measured during a maximal exercise test on an electronically braked cycle ergometer according to a ramp protocol [ 34 ], in which the resistance gradually increases every 6 s aiming to achieve the maximum within 8 to 12 min. For children and adolescents, the Godfrey protocol is used [ 35 ]. In this protocol, patients will begin pedalling at 0 W for 1 min, and the workload increases by 10, 15 or 20 W each minute depending on the patients’ height and clinical status [ 35 ]. All patients are instructed to cycle with a pedal frequency between 70 and 80 rpm and are encouraged to continue exercising until exhaustion, or inability to maintain the pedal frequency of 70 rpm. Expired gases are collected and analysed breath by breath for O 2 , CO 2 and volume. The average values of the last 30 s of exercise are used as measures for peak oxygen uptake (peakVO 2 , in litres per minute), peak power output (peakW, in watt) and peak heart rate (HR). Ventilatory threshold is determined by using the oxygen equivalent method [ 36 ]. HR and respiratory exchange ratio are used as objective criteria for peak exercise.

In the RCT evaluating exercise during chemotherapy, peakVO 2 cannot be determined directly, due to logistic reasons. Therefore, an estimation of peakVO 2 is made based on the steep ramp test using a linear regression equation [ 30 ]. This has been shown to be a reliable (ICC = 0.996) and valid method to estimate cardiorespiratory fitness in cancer patients [ 30 ]. In the other three A-CaRe trials, the steep ramp test is performed for adjustments of training intensities.

Muscle Strength

Upper extremity muscle strength of adults is measured using a JAMAR grip strength dynamometer. Handgrip can be used to characterize general upper extremity muscle strength [ 37 – 39 ] and can increase after general upper extremity resistance training including exercises that did not specifically involve handgrip strength [ 40 ].

Lower extremity muscle strength of adults is tested by the functional 30-s chair stand test. This test is a valid and reliable measure of lower extremity strength in adults [ 41 ]. Patients are asked to stand upright from a chair with the arms folded across the chest, then to sit down again and repeat the action over a 30-s period. The number of times that the patient rises to a full stand from the seated position within 30 s is recorded [ 42 – 44 ].

For children and adolescents, upper and lower extremity muscle strength is assessed using a handheld dynamometer. Upper extremity muscles include grip, shoulder abductor and wrist extensor strength. In the lower extremity, muscle strength of the hip flexors and the knee and dorsal foot extensors is measured. Three consecutive measurements are performed using the ‘break method’, in which the examiner gradually overcomes the muscle force and stops at the moment the extremity gives way [ 45 ]. The highest value will be registered.

Fatigue

In adults, fatigue symptoms are assessed with the Multidimensional Fatigue Inventory (MFI) [ 46 ]. The MFI contains 20 items, organized into five scales: general fatigue, physical fatigue, reduced activity, reduced motivation and mental fatigue. The MFI subscales have good internal consistency (average Cronbach’s alpha = 0.84) [ 47 ].

In addition, adults’ perception and appraisal of experienced fatigue are assessed with the Fatigue Quality List (FQL) [ 48 ]. The FQL consists of 25 adjectives describing the fatigue experience, organized into four subscales: frustrating, exhausting, pleasant and frightening.

Secondary Outcome Measures

Fatigue in Children

In children, fatigue is assessed by the 18-item Paediatric Quality of Life Inventory (PedsQL) Multidimensional Fatigue Scale Acute Version, which is designed to measure both the child’s and parents’ perception of fatigue in paediatric patients [ 49 ]. It consists of three subscales: general fatigue (six items), sleep rest fatigue (six items) and cognitive fatigue. Both parent and child reports were shown to be valid and reliable in childhood cancer [ 49 ].

Mood Disturbances

In adults, mood disturbances are assessed with the 14-item Hospital Anxiety and Depression Scale (HADS) [ 50 , 51 ]. It yields a total score and separate scale scores for anxiety and depression. Numerous studies have applied the HADS to assess distress among cancer patients [ 52 – 54 ]. Furthermore, the questionnaire has been validated for use in the Dutch population [ 55 ].

The Children’s Depression Inventory is used to assess symptoms of depression in children and adolescents with cancer. Overall, this questionnaire has good internal consistency and test–retest reliability and a positive correlation with clinicians’ independent global depression ratings [ 56 ].

Sleep Disturbances

Sleep disturbances are assessed with the Pittsburgh Sleep Quality Index (PSQI), an 18-item, self-rated questionnaire assessing the quality of sleep and sleep disturbances over a month [ 57 ]. A total score is derived as well as seven subscales that include subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication and daytime dysfunction. Scores ≥ 5 on the PSQI total scale, computed as the sum of the seven subscales are associated with clinically significant sleep disturbances [ 57 ].

Health-Related Quality of Life

In adults, HRQoL is assessed with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30), a questionnaire specifically developed to asses HRQoL in cancer patients [ 58 ]. It consists of 30 items, organized into five functional scales (physical, role, emotional, cognitive, social), three symptom scales (pain, fatigue and emesis) and an overall quality of life scale. Additional single items address other symptoms commonly experienced by cancer patients (e.g. insomnia, diarrhoea, constipation etc.). Validity and reliability of the questionnaire have been established [ 58 ].

HRQoL in children and adolescents with cancer is assessed by child self-report and parent-proxy report using the PedsQL 4.0 Generic Core Scale and the PedsQL 3.0 Cancer module. The PedsQL 4.0 Generic Core Scale is a 23-item questionnaire encompassing physical, emotional, social and school functioning domains. The PedsQL 3.0 Cancer module is a 27-item multidimensional cancer-specific questionnaire that encompasses eight scales: pain and hurt, nausea, procedural anxiety, treatment anxiety, worry, cognitive problems, perceived physical appearance and communication. Validity and reliability of both child and parent reports of the PedsQL Generic Core Scale and the Cancer Module has been shown [ 49 , 59 ].

Self-Perception and Behavioural Problems in Children and Adolescents

The Dutch version of the Self-Perception profile for children (CBSK) and adolescents (CBSA) is used to assess self-perception of scholastic competence, social acceptance, physical appearance, behavioural conduct, global self-worth and close friendships. The questionnaire has good reliability and validity when used in children 8 years and older [ 60 , 61 ].

Internalizing and externalizing behavioural problems are assessed using the Dutch translated and validated Child Behaviour Checklist (CBCL) for children younger than 11 years. The CBCL is a valid and reliable instrument to assess the parents’ evaluation of internalizing and externalizing behaviour problems of children [ 62 ]. For children aged 11 to 18 years old, the Youth Self Report is used.

Functioning in Daily Life

The Impact on Participation and Autonomy (IPA) Questionnaire is used to assess functioning in daily life of adults [ 63 ]. The IPA consists of 32 items assessing perceived level of participation and autonomy, organized into five domains: autonomy in the home, family role, autonomy outside of the home, social relations and work and education. An additional nine items assess perceived problems with participation and autonomy. Internal consistency of the five domain scores range from 0.81 to 0.91.

Physical Activity

Objective levels of physical activity are assessed using an accelerometer, a small and lightweight device, which detects accelerations. Patients wear the accelerometer on the right hip attached to a belt for 4–7 days, including at least one weekend day. Although accelerometers may underestimate some activities, such as cycling and water activities, it is recognised as a reasonably valid tool to objectively assess physical activity in adults [ 64 ], as well as in children [ 65 – 67 ]. Accelerations are converted into activity counts per minute, indicating the level of physical activity.

Self-reported physical activity of adults is assessed using the Physical Activity Scale for the Elderly (PASE). The PASE is a brief, self-administered 7-day recall questionnaire, which consists of questions on leisure time, household and work-related physical activities [ 68 ]. The frequency of activities is recorded as never, seldom (1 to 2 days/week), sometimes (3 to 4 days/week) or often (5–7 days/week). The duration of activities is categorized as less than 1 h, between 1 and 2 h, between 2 and 4 h or more than 4 h. Paid or unpaid work, except for work that involves mostly sitting activities such as office work, is categorized as less than 1 h, between 1 and 4 h, between 5 and 8 h or more than 8 h [ 69 ]. The total activity score is computed by multiplying the amount of time spent on each activity (in hours per week) by the empirically derived item weights and summing over all activities [ 68 ]. In healthy adults, the PASE has shown to have high test–retest reliability ( r = 0.84) [ 68 ] and reasonable validity as compared with the doubly labelled water method ( r = 0.58) [ 70 ]. Results from our institution showed that the PASE had good to excellent test-retest reliability in cancer patients and good content validity [ 71 ].

Body Composition

Body height and body weight are assessed in all patients, and BMI is calculated. In addition, fat mass, muscle mass and bone mineral density will be assessed by whole body dual energy X-ray scans in adults, children and adolescents, except for participants from the exercise intervention during chemotherapy, due to logistic reasons. In adults, also waist and hip circumferences and thickness of four skinfolds (biceps, triceps, suprailiacal, subscapular) are assessed.

Return to Work or School

The following indicators of return to work (RTW) or school (RTS) are measured using self-reported calendars: time to partial and to full RTW or RTS expressed in number of calendar days between the end of treatment and the first day at work, time to full RTW or RTS corrected for partial RTW or RTS and partial and full RTW or RTS rate at T0, T1 and T2.

Covariates

Sociodemographic and Clinical Data

Sociodemographic data, including age, (parental) education, marital status, living situation, work (or school) status, medication use and lifestyle variables (e.g. smoking, physical activity prior to diagnosis), are collected at baseline.

Clinical information is collected from the medical records and includes date of diagnosis, stage and subtype of disease, treatment history, type and dose of chemotherapy and/or radiotherapy and adverse events during treatment. During the follow-up period, data on disease status (response to treatment, progression or relapse) and data on any additional treatment are collected.

Moderating Variables

At baseline, a series of questions is asked to assess potential moderating variables including pre-illness lifestyle (frequency, nature and intensity of physical activity and exercise behaviour, or avoidance thereof), current attitudes towards and beliefs about exercise in general and exercise during or after treatment. Information about behavioural, normative and control beliefs about exercise, attitude towards exercise, subjective norm, perceived behavioural control and intention is collected using standardized questions as described by Courneya et al. [ 72 , 73 ]. These questions have previously been used to evaluate exercise programmes in cancer patients and survivors and are based on established health behaviour theories, in particularly the Theory of Planned Behaviour [ 74 ].

Adherence

Compliance with the interventions is assessed by self-report, and attendance and exercise logs filled in by physical therapists and psychologist (e.g. observed attendance at and compliance with the exercise). Non-responders and dropouts receive a short questionnaire to assess the reason for non-participation or dropping out of the study.

Satisfaction with Intervention

After completion of the intervention programmes, patients are asked to complete a brief questionnaire addressing the perceived efficacy of and satisfaction with the programme, whether they would suggest any changes to the programme and if they would recommend it to other patients undergoing similar treatments.

Adverse Effects

Adverse effects of the rehabilitation programmes in adult patients are actively monitored during the study with a special emphasis on increased fatigue, reported by the patients, physiotherapists, sports physicians or trainers and checked in the medical records. In addition, in patients from the RCTs that evaluate training after chemotherapy and after stem cell transplantation, neurotoxicity is evaluated using the Chemotherapy-Induced Peripheral Neuropathy (CIPN20) questionnaire [ 75 ]. This is an EORTC quality of life questionnaire that is specifically developed to assess chemotherapy-induced peripheral neuropathy.

Costs from a Societal Perspective

Besides the costs of the exercise programmes, data on health care costs, patient and family costs and costs of production losses are collected using monthly cost diaries measured on a three-monthly basis during the entire follow-up period. Health care costs include the costs of oncological care, general practice care and physiotherapy, additional visits to other health care providers, prescription of medication, professional home care and hospitalization. Patient and family costs include out-of-pocket expenses such as travel expenses and costs for paid and unpaid help. Costs related to production losses include work absenteeism for patients (or parents) with paid jobs and days of inactivity for patients (or parents) without a paid job.

Utilities are measured using the EuroQol (EQ5D) [ 76 ]. The EQ5D is a health-related quality of life measure that provides a single index of an individual’s quality of life. It consists of five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety and depression. Each dimension is rated as ’no problem’, ‘some problem’ or ‘extreme problem’, resulting in 243 possible health states [ 76 ]. Dutch tariffs will be used to value these health states [ 77 ].

Statistical Analyses

Data will be analysed on an intention-to-treat basis, in which all patients will be included in the group they were allocated to by randomization. In addition, a per-protocol analysis will be performed in which we only include participants who completed the intervention they were allocated to according to the protocol. Completing the intervention is defined as having attained 75% of all training sessions.

Multi-level longitudinal regression analysis will be conducted to assess between-group differences in each outcome measure. The follow-up value will be defined as the dependent variable and the following levels will be used: (1) time of follow-up measurement (values corresponding with performance at T1 and T2), (2) training centre and (3) individual. Regression coefficients indicate differences between intervention and control groups. Regression models will be adjusted for the baseline values of the respective outcome measures. Missing values will be avoided as much as possible by asking participants to comply to the post-test and follow-up measurement even after they drop out from the exercise programme. Missing values will be accounted for in the mixed linear regression modelling.

Costs are valued using the guidelines published in the updated handbook for economic evaluation in The Netherlands, issued by the Dutch Health Care Insurance Board [ 78 ]. Both incremental cost-effectiveness and cost–utility analyses are performed. The cost-effectiveness ratio is calculated by dividing the difference between the mean total costs of the exercise and control groups by the difference in mean effects of the group(s) [ 79 ]. The primary clinical effect measures of the trials will be included in the cost-effectiveness analyses. The cost–utility ratio expresses the additional costs of the intervention compared with the control group per quality adjusted life years. Cost-effectiveness and cost–utilities ratios are estimated using bootstrapping techniques and uncertainty of these ratios graphically presented on cost-effectiveness and cost–utility planes, and acceptability curves [ 79 , 80 ]. Sensitivity analyses on the most important cost drivers are performed in order to assess the robustness of results.

Discussion

This paper presents the design and methods of four randomized controlled trials on exercise-based rehabilitation programmes included in the A-CaRe Clinical Research programme. These studies are designed to evaluate the effectiveness and cost-effectiveness of exercise-based rehabilitation programmes in different cancer patient and survivor groups. The outcome measures of the studies are carefully chosen based on the ICF, and the instrumentation is standardized, valid and reliable. It is hypothesized that exercise-based rehabilitation programmes are more effective at improving cardiorespiratory fitness and muscle strength, and thereby reducing fatigue, and more cost-effective compared with usual care or a waiting list control group. In addition, we compare the results of high-intensity training to low-to-moderate intensity training.

Unlike cardiovascular diseases or other chronic conditions, exercise-based rehabilitation programmes are currently not part of standard health care for cancer patients and survivors in The Netherlands. Before being able to implement cancer rehabilitation programmes on a large scale, the efficacy of such programmes need to be established. This is the main aim of the A-CaRe programme. In addition to the evaluation of the effectiveness and cost-effectiveness of the exercise interventions, we need to gain insight in how (mediators), for whom and under what circumstances (moderators) these interventions are effective. Insight in mediators and moderators of exercise interventions is essential to be able to tailor cancer rehabilitation programmes to the needs, preferences and characteristics of individual cancer patients. With the large database resulting from the four A-CaRe trials, we will be able to explore several mediators and moderators of exercise-based cancer rehabilitation programmes.

In conclusion, the four A-CaRe trials evaluate the effectiveness and the cost-effectiveness of various exercise-based rehabilitation programmes in cancer patients and survivors, in comparison with usual care or no treatment.

Abbreviations

Alpe d’HuZes Cancer Rehabilitation

Health-related quality of life

Peak oxygen uptake

Randomized controlled trial

Laurien Buffart and Mai Chinapaw share first authorship since they have equally contributed to this manuscript.

Trial registration

This study is registered at the Netherlands Trial Register: NTR2153 (study 1), NTR2159 (study 2), NTR2341 (study 3) and NTR1531 (study 4).

This study is supported by the Alpe d’HuZes/KWF Fund. The research grant is provided by the Dutch Cancer Society. The contribution of L.M. Buffart was further supported by a fellowship granted by the EMGO Institute for Health and Care Research. In addition, the authors acknowledge the A-CaRe Clinical Research group ( www.a-care.org ): from the VU University Medical Center Amsterdam, EMGO Institute for Health and Care Research: J. Brug (Ph.D.), M.J.M. Chinapaw (Ph.D.), L.M. Buffart (Ph.D.), W. van Mechelen (MD, Ph.D.) and C.S. Kampshoff (M.Sc.); from the Department of Pediatric Oncology/Hematology: G.J.L. Kaspers (MD, Ph.D.), E. van Dulmen-den Broeder (Ph.D.), M. Veening (MD, Ph.D.) and K.I. Braam (M.Sc.); from the Department of Medical Psychology: J. Huisman (Ph.D.) and E.M. van Dijk (MA); from The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL) Amsterdam: N.K. Aaronson (Ph.D.), W.H. van Harten (MD, Ph.D.), G. Sonke (MD, Ph.D.), M.M. Stuiver (PT, M.Sc.) and H. van Waart (M.Sc.); from the University Medical Center Utrecht, Child Development & Exercise Center: T. Takken (Ph.D.); from Máxima Medical Center Veldhoven: G. Schep (MD, Ph.D.) and S. Houterman (Ph.D.); from the Academic Medical Center, Amsterdam, Department of Rehabilitation, F. Nollet (MD, Ph.D.) and S. Persoon (M.Sc.) and from the Department of Hematology: M.J. Kersten (MD, Ph.D.).

Competing interests

The authors declare that they have no competing interests.

Disclosure of interest

All authors have no financial relationship with the organization that sponsored the research. They have full control of all primary data and that they agree to allow the journal to review their data if requested.

Open Access

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

References

1. IKCnet (2009) Dutch Cancer Registration. Survival. http://wwwikcnetnl

2. Hudson MM Mertens AC Yasui Y Hobbie W Chen H Gurney JG Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study JAMA 2003 290 12 1583 1592 10.1001/jama.290.12.1583 14506117

3. Reedijk AM Janssen-Heijnen ML Louwman MW Snepvangers Y Hofhuis WJ Coebergh JW Increasing incidence and improved survival of cancer in children and young adults in Southern Netherlands, 1973–1999 Eur J Cancer 2005 41 5 760 769 10.1016/j.ejca.2004.11.022 15763653

4. Courneya KS Friedenreich CM Physical exercise and quality of life following cancer diagnosis: a literature review Ann Behav Med 1999 21 2 171 179 10.1007/BF02908298 10499138

5. Courneya KS Exercise in cancer survivors: an overview of research Med Sci Sports Exerc 2003 35 11 1846 1852 10.1249/01.MSS.0000093622.41587.B6 14600549

6. Lucia A Earnest C Perez M Cancer-related fatigue: can exercise physiology assist oncologists? Lancet Oncol 2003 4 10 616 625 10.1016/S1470-2045(03)01221-X 14554239

7. Curt GA Breitbart W Cella D Groopman JE Horning SJ Itri LM Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition Oncologist 2000 5 5 353 360 10.1634/theoncologist.5-5-353 11040270

8. de Jong N Courtens AM bu-Saad HH Schouten HC Fatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of the literature Cancer Nurs 2002 25 4 283 297 10.1097/00002820-200208000-00004 12181497

9. Dimeo FC Effects of exercise on cancer-related fatigue Cancer 2001 92 6 Suppl 1689 1693 10.1002/1097-0142(20010915)92:6+<1689::AID-CNCR1498>3.0.CO;2-H 11598888

10. Smith M Hare ML An overview of progress in childhood cancer survival J Pediatr Oncol Nurs 2004 21 3 160 164 10.1177/1043454204264407 15296046

11. Geenen MM Cardous-Ubbink MC Kremer LC van den Bos C van der Pal HJ Heinen RC Medical assessment of adverse health outcomes in long-term survivors of childhood cancer JAMA 2007 297 24 2705 2715 10.1001/jama.297.24.2705 17595271

12. Van Brussel M Takken T Lucia A van der Net J Helders PJ Is physical fitness decreased in survivors of childhood leukemia? A systematic review Leukemia 2005 19 1 13 17 15526028 10.1038/sj.leu.2403547

13. Galvao DA Newton RU Review of exercise intervention studies in cancer patients J Clin Oncol 2005 23 4 899 909 10.1200/JCO.2005.06.085 15681536

14. Knols R Aaronson NK Uebelhart D Fransen J Aufdemkampe G Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials J Clin Oncol 2005 23 16 3830 3842 10.1200/JCO.2005.02.148 15923576

15. Liu RD Chinapaw MJ Huijgens PC van Mechelen W Physical exercise interventions in haematological cancer patients, feasible to conduct but effectiveness to be established: a systematic literature review Cancer Treat Rev 2009 35 2 185 192 10.1016/j.ctrv.2008.09.008 19004560

16. Stevinson C Lawlor DA Fox KR Exercise interventions for cancer patients: systematic review of controlled trials Cancer Causes Control 2004 15 10 1035 1056 10.1007/s10552-004-1325-4 15801488

17. Schmitz KH Holtzman J Courneya KS Masse LC Duval S Kane R Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis Cancer Epidemiol Biomark Prev 2005 14 7 1588 1595 10.1158/1055-9965.EPI-04-0703 16030088

18. Watson T Mock V Exercise as an intervention for cancer-related fatigue Phys Ther 2004 84 8 736 743 15283624

19. De Backer I van Breda E Vreugdenhil A Nijziel MR Kester AD Schep G High-intensity strength training improves quality of life in cancer survivors Acta Oncol 2007 46 8 1143 1151 10.1080/02841860701418838 17851864

20. Argiles JM Busquets S Felipe A Lopez-Soriano FJ Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia Int J Biochem Cell Biol 2005 37 5 1084 1104 10.1016/j.biocel.2004.10.003 15743680

21. May AM van Weert E Korstjens I Hoekstra-Weebers JE van der Schans CP Zonderland ML Improved physical fitness of cancer survivors: a randomised controlled trial comparing physical training with physical and cognitive-behavioural training Acta Oncol 2008 47 5 825 834 10.1080/02841860701666063 17917819

22. van Weert E Hoekstra-Weebers JE May AM Korstjens I Ros WJ van der Schans CP The development of an evidence-based physical self-management rehabilitation programme for cancer survivors Patient Educ Couns 2008 71 2 169 190 10.1016/j.pec.2007.11.027 18255249

23. May AM Korstjens I van Weert E van den Borne B Hoekstra-Weebers JE van der Schans CP Long-term effects on cancer survivors’ quality of life of physical training versus physical training combined with cognitive-behavioral therapy: results from a randomized trial Support Care Cancer 2009 17 6 653 663 10.1007/s00520-008-0519-9 18953578

24. De Backer I Vreugdenhil G Nijziel MR Kester AD van Breda E Schep G Long-term follow-up after cancer rehabilitation using high-intensity resistance training: persistent improvement of physical performance and quality of life Br J Cancer 2008 99 1 30 36 10.1038/sj.bjc.6604433 18577993 PMC2453017

25. Kampshoff CS Buffart LM Schep G van Mechelen W Brug J Chinapaw MJ Design of the Resistance and Endurance exercise After ChemoTherapy (REACT) study: a randomized controlled trial to evaluate the effectiveness and cost-effectiveness of exercise interventions after chemotherapy on physical fitness and fatigue BMC Cancer 2010 10 658 10.1186/1471-2407-10-658 21118564 PMC3009679

26. van Waart H Stuiver MM van Harten WH Sonke GS Aaronson NK Design of the Physical exercise during Adjuvant Chemotherapy Effectiveness Study (PACES): a randomized controlled trial to evaluate effectiveness and cost-effectiveness of physical exercise in improving physical fitness and reducing fatigue BMC Cancer 2010 10 673 10.1186/1471-2407-10-673 21138561 PMC3002358

27. Persoon S Kersten MJ Chinapaw MJ Buffart LM Burghout H Schep G Design of the EXercise Intervention after Stem cell Transplantation (EXIST) study: a randomized controlled trial to evaluate the effectiveness and cost-effectiveness of an individualized high intensity physical exercise program on fitness and fatigue in patients with multiple myeloma or (non-) Hodgkin’s lymphoma treated with high dose chemotherapy and autologous stem cell transplantation BMC Cancer 2010 10 671 10.1186/1471-2407-10-671 21134270 PMC3016293

28. Braam KI van Dijk EM Veening MA Bierings MB Merks JH Grootenhuis MA Design of the Quality of Life in Motion (QLIM) study: a randomized controlled trial to evaluate the effectiveness and cost-effectiveness of a combined physical exercise and psychosocial training program to improve physical fitness in children with cancer BMC Cancer 2010 10 624 10.1186/1471-2407-10-624 21070639 PMC2996394

29. Gielissen MF Schattenberg AV Verhagen CA Rinkes MJ Bremmers ME Bleijenberg G Experience of severe fatigue in long-term survivors of stem cell transplantation Bone Marrow Transplant 2007 39 10 595 603 10.1038/sj.bmt.1705624 17369868

30. De Backer I Schep G Hoogeveen A Vreugdenhil G Kester AD van Breda E Exercise testing and training in a cancer rehabilitation program: the advantage of the steep ramp test Arch Phys Med Rehabil 2007 88 5 610 616 10.1016/j.apmr.2007.02.013 17466730

31. Borg GA Psychophysical bases of perceived exertion Med Sci Sports Exerc 1982 14 5 377 381 7154893

32. World Health Organisation ICF-international classification of functioning, disability and health 2001 Geneva WHO

33. Gilchrist LS Galantino ML Wampler M Marchese VG Morris GS Ness KK A framework for assessment in oncology rehabilitation Phys Ther 2009 89 3 286 306 10.2522/ptj.20070309 19147708 PMC2967778

34. Anonymous. Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies. ERS Task Force on Standardization of Clinical Exercise Testing. European Respiratory Society. Eur Respir J. 1997;(11):2662–89. 10.1183/09031936.97.10112662 9426113

35. Godfrey S Exercise testing in children 1974 London Saunders

36. Wasserman K Critical capillary PO2 and the role of lactate production in oxyhemoglobin dissociation during exercise Adv Exp Med Biol 1999 471 321 333 10.1007/978-1-4615-4717-4_39 10659163

37. Bohannon RW Hand-grip dynamometry provides a valid indication of upper extremity strength impairment in home care patients J Hand Ther 1998 11 4 258 260 10.1016/S0894-1130(98)80021-5 9862263

38. Bohannon RW Is it legitimate to characterize muscle strength using a limited number of measures? J Strength Cond Res 2008 22 1 166 173 10.1519/JSC.0b013e31815f993d 18296971

39. Bohannon RW Dynamometer measurements of grip and knee extension strength: are they indicative of overall limb and trunk muscle strength? Percept Mot Skills 2009 108 2 339 342 10.2466/pms.108.2.339-342 19544938

40. Magnussen Thomas E Sahlberg M Svantesson U The effect of resistance training on handgrip strength in young adults Isokinet Exerc Sci 2009 16 125 131

41. Rikli RE Jones CJ Development and validation of a functional fitness test for community-residing older adults J Aging Phys Act 1999 7 129 161

42. Csuka M McCarty DJ Simple method for measurement of lower extremity muscle strength Am J Med 1985 78 1 77 81 10.1016/0002-9343(85)90465-6 3966492

43. Jones CJ Rikli RE Beam WC A 30-s chair-stand test as a measure of lower body strength in community-residing older adults Res Q Exerc Sport 1999 70 2 113 119 10380242 10.1080/02701367.1999.10608028

44. Rikli RE Jones CJ Functional fitness normative scores for community-residing older adults, ages 60–94 J Aging Phys Act 1999 7 162 181

45. Backman E Methods for measurement of muscle function. Methodological aspects, reference values for children, and clinical applications Scand J Rehabil Med Suppl 1988 20 9 95 3074485

46. Smets EM Garssen B Bonke B de Haes JC The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue J Psychosom Res 1995 39 3 315 325 10.1016/0022-3999(94)00125-O 7636775

47. Smith KB Pukall CF An evidence-based review of yoga as a complementary intervention for patients with cancer Psychooncology 2009 18 5 465 475 10.1002/pon.1411 18821529

48. Gielissen MF Knoop H Servaes P Kalkman JS Huibers MJ Verhagen S Differences in the experience of fatigue in patients and healthy controls: patients’ descriptions Health Qual Life Outcomes 2007 5 36 10.1186/1477-7525-5-36 17605783 PMC1934901

49. Varni JW Burwinkle TM Katz ER Meeske K Dickinson P The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module Cancer 2002 94 7 2090 2106 10.1002/cncr.10428 11932914

50. Snaith P Zigmond AS Anxiety and depression in general medical settings BMJ 1988 297 6662 1544 10.1136/bmj.297.6662.1544 3147074 PMC1835212

51. Zigmond AS Snaith RP The hospital anxiety and depression scale Acta Psychiatr Scand 1983 67 6 361 370 10.1111/j.1600-0447.1983.tb09716.x 6880820

52. Adamsen L Quist M Midtgaard J Andersen C Moller T Knutsen L The effect of a multidimensional exercise intervention on physical capacity, well-being and quality of life in cancer patients undergoing chemotherapy Support Care Cancer 2006 14 2 116 127 10.1007/s00520-005-0864-x 16096771

53. Browall M Ahlberg K Karlsson P Danielson E Persson LO Gaston-Johansson F Health-related quality of life during adjuvant treatment for breast cancer among postmenopausal women Eur J Oncol Nurs 2008 12 3 180 189 10.1016/j.ejon.2008.01.005 18343197

54. Thorsen L Skovlund E Stromme SB Hornslien K Dahl AA Fossa SD Effectiveness of physical activity on cardiorespiratory fitness and health-related quality of life in young and middle-aged cancer patients shortly after chemotherapy J Clin Oncol 2005 23 10 2378 2388 10.1200/JCO.2005.04.106 15800330

55. Spinhoven P Ormel J Sloekers PP Kempen GI Speckens AE van Hemert AM A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects Psychol Med 1997 27 2 363 370 10.1017/S0033291796004382 9089829

56. Kovacs M Rating scales to assess depression in school-aged children Acta Paedopsychiatr 1981 46 5–6 305 315 7025571

57. Buysse DJ Reynolds CF III Monk TH Berman SR Kupfer DJ The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research Psychiatry Res 1989 28 2 193 213 10.1016/0165-1781(89)90047-4 2748771

58. Aaronson NK Ahmedzai S Bergman B Bullinger M Cull A Duez NJ The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 1993 85 5 365 376 10.1093/jnci/85.5.365 8433390

59. Varni JW Limbers CA Burwinkle TM Impaired health-related quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the PedsQL 4.0 Generic Core Scales Health Qual Life Outcomes 2007 5 43 10.1186/1477-7525-5-43 17634123 PMC1964786

60. Treffers PDA Goedhart AW Veerman JW van den Berg BRH Ackaert L De Rycke L De competentiebelevingsschaal voor adolescenten CBSA. Handleiding 2003 Lisse Swets Test

61. Veerman JW Straathof MAE Treffers PDA van den Berg BRH Ten Brink LT De competentiebelevingsschaal voor kinderen CBSK. Handleiding 1997 Lisse Swets & Zeitlinger

62. Verhulst FC Koot JM Akkerhuis GW Veerman JW Praktische handleiding voor de CBCL (Child Behavior Checklist) 1990 Assen/Maastricht van Gorcum

63. Cardol M Beelen A van den Bos GA De Jong BA de Groot IJ de Haan RJ Responsiveness of the Impact on Participation and Autonomy questionnaire Arch Phys Med Rehabil 2002 83 11 1524 1529 10.1053/apmr.2002.35099 12422319

64. Bassett DR Jr Ainsworth BE Swartz AM Strath SJ O’Brien WL King GA Validity of four motion sensors in measuring moderate intensity physical activity Med Sci Sports Exerc 2000 32 9 Suppl S471 S480 10993417 10.1097/00005768-200009001-00006

65. Esliger DW Tremblay MS Technical reliability assessment of three accelerometer models in a mechanical setup Med Sci Sports Exerc 2006 38 12 2173 2181 10.1249/01.mss.0000239394.55461.08 17146326

66. Pfeiffer KA McIver KL Dowda M Almeida MJ Pate RR Validation and calibration of the Actical accelerometer in preschool children Med Sci Sports Exerc 2006 38 1 152 157 10.1249/01.mss.0000183219.44127.e7 16394968

67. Puyau MR Adolph AL Vohra FA Butte NF Validation and calibration of physical activity monitors in children Obes Res 2002 10 3 150 157 10.1038/oby.2002.24 11886937

68. Washburn RA Smith KW Jette AM Janney CA The Physical Activity Scale for the Elderly (PASE): development and evaluation J Clin Epidemiol 1993 46 2 153 162 10.1016/0895-4356(93)90053-4 8437031

69. Washburn RA Zhu W McAuley E Frogley M Figoni SF The physical activity scale for individuals with physical disabilities: development and evaluation Arch Phys Med Rehabil 2002 83 2 193 200 10.1053/apmr.2002.27467 11833022

70. Schuit AJ Schouten EG Westerterp KR Saris WH Validity of the Physical Activity Scale for the Elderly (PASE): according to energy expenditure assessed by the doubly labeled water method J Clin Epidemiol 1997 50 5 541 546 10.1016/S0895-4356(97)00010-3 9180646

71. Liu RD, Buffart LM, Kersten MJ, Spiering M, Brug J, van Mechelen W, Chinapaw MJ. Psychometric properties of two physical activity questionnaires, the AQuAA and the PASE, in cancer patients. BMC Med Res Methodol 2011;11:30. 10.1186/1471-2288-11-30 PMC3079697 21410979

72. Courneya KS Understanding readiness for regular physical activity in older individuals: an application of the theory of planned behavior Health Psychol 1995 14 1 80 87 10.1037/0278-6133.14.1.80 7737078

73. Courneya KS Friedenreich CM Utility of the theory of planned behavior for understanding exercise during breast cancer treatment Psychooncology 1999 8 2 112 122 10.1002/(SICI)1099-1611(199903/04)8:2<112::AID-PON341>3.0.CO;2-L 10335555

74. Ajzen I The theory of planned behavior Organ Behav Hum Decis Process 1999 50 179 211 10.1016/0749-5978(91)90020-T

75. Postma TJ Aaronson NK Heimans JJ Muller MJ Hildebrand JG Delattre JY The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20 Eur J Cancer 2005 41 8 1135 1139 10.1016/j.ejca.2005.02.012 15911236

76. Uyl-de Groot CA Rutten FF Bonsel GJ Measurement and valuation of quality of life in economic appraisal of cancer treatment Eur J Cancer 1994 30A 1 111 117 10.1016/S0959-8049(05)80030-9 8142152

77. Lamers LM Stalmeier PF McDonnell J Krabbe PF van Busschbach JJ Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff Ned Tijdschr Geneeskd 2005 149 28 1574 1578 16038162

78. Oostenbrink JB Handbook for cost studies: methods and standard costs for economic evaluation in health care. Updated version 2004 The Hague Dutch Health Insurance Counsel

79. Drummond MF Sculpher MJ Torrance GW O’Brien BJ Stoddart GL Methods for the economic evaluation of health care programmes 2005 New York Oxford University Press

80. Stinnett AA Mullahy J Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis Med Decis Mak 1998 18 2 Suppl S68 S80 10.1177/0272989X9801800209 9566468